sotatercept
merck
['stellar', 'sotatercept']
#acc2023 late-breaking clinical trials. sotatercept, a stellar new treatment for our pah patients!! 6mwd 40.8 m. secondary efficacy endpoints: 84% time to death/first non-fatal clinical worsening event 
Cardiólogo, especialista en Insuficiencia Cardiaca e Hipertensión Pulmonar